文献速递新生儿儿童神经与发育行为

新生儿体外膜氧合支持期间神经系统并发症的临床分析

[Clinical analysis of neurologic complications in neonates during extracorporeal membrane oxygenation support].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2026-01-01

该回顾性队列研究纳入47例接受ECMO的新生儿,38%出现神经系统损伤,以颅内出血和亚临床惊厥为主。神经系统损伤组ECMO启动前后PCO2差值更大(P=0.023),且撤机成功率和出院存活率均更低(均P<0.05)。

要点

  • 新生儿ECMO期间神经系统损伤发生率为38%,以颅内出血和亚临床惊厥为主。
  • ECMO启动前后PCO2差值较大可能与神经系统损伤相关(P=0.023)。
  • 发生神经系统损伤者撤机成功率和出院存活率均更低(均P<0.05)。

核心结论

  • 新生儿ECMO治疗期间神经系统并发症发生率较高,以颅内出血和亚临床惊厥为主,是造成死亡和不良神经发育预后的重要原因。
  • ECMO启动前PCO2的急剧波动可能是神经损伤的危险因素。

研究设计与样本

  • 回顾性队列研究,纳入2020年3月至2025年8月广州医科大学附属妇女儿童医疗中心新生儿科接受ECMO治疗的47例患儿。
  • 根据是否发生神经系统损伤分为神经系统损伤组(18例)和无神经系统损伤组(29例),比较基线资料、ECMO运行参数、头颅影像学、脑电图及神经发育评估结果。

主要发现

  • 47例患儿中男35例(74%),出生胎龄39.4(38.0,40.0)周,出生体重3 200(2 855,3 440)g。
  • 原发疾病为新生儿持续性肺动脉高压17例(36%)、胎粪吸入综合征14例(30%)、新生儿败血症7例(15%)、重症肺炎4例(9%)。
  • 18例(38%)出现神经系统损伤,包括颅内出血13例、惊厥7例均为亚临床发作、脑电图显著抑制2例和脑梗死1例。
  • 神经系统损伤组ECMO启动前后动脉血PCO2差值高于无神经系统损伤组(P=0.023),两组基线情况、ECMO运行参数、抗凝治疗差异均无统计学意义(均P>0.05)。
  • ECMO撤机成功40例(85%),出院存活34例(72%);神经系统损伤组成功撤机12例、存活出院7例,无损伤组成功撤机28例、存活出院27例,两组撤机成功率和出院存活率差异均有统计学意义(均P<0.05)。

关键数值与推荐

  • 神经系统损伤组ECMO启动前后动脉血PCO2差值高于无神经系统损伤组(P=0.023)。
  • 神经系统损伤组与无神经系统损伤组的成功撤机率和出院存活率差异均有统计学意义(均P<0.05)。
  • 34例存活患儿随访至2岁,发生癫痫2例、脑性瘫痪1例;23例在24月龄内完成至少1次神经发育评估,其中3月龄神经发育评估18例中异常3例。

临床怎么用

  • 新生儿ECMO支持期间应关注神经系统并发症,尤其是颅内出血和亚临床惊厥。
  • ECMO启动前后应关注动脉血PCO2的急剧波动,可能有助于降低神经损伤风险。
  • 发生神经系统损伤的患儿撤机成功率和出院存活率更低,需加强围ECMO期神经监测与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the incidence, risk factors, and outcomes of neurological complications in neonates undergoing extracorporeal membrane oxygenation (ECMO). Methods: A retrospective cohort study was conducted. A total of 47 neonates who received ECMO support in the Division of Neonatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, from March 2020 to August 2025 were included. Data on baseline characteristics, ECMO operational parameters, cranial imaging, electroencephalogram, and neurodevelopmental assessments were collected. Based on the presence of neurological injury, neonates were categorized into neurological injury and non-neurological injury groups. Independent samples t test, Mann-Whitney U test, χ² tests or Fisher exact tests were used to compare the difference between groups. Results: Among the 47 neonates, 35 cases (74%) were male, with a gestational age at birth of 39.4 (38.0, 40.0) weeks and a birth weight of 3 200 (2 855, 3 440) g. Primary etiologies from cardiopulmonary failure included persistent pulmonary hypertension of the newborn (17 cases (36%)), meconium aspiration syndrome (14 cases (30%)), neonatal sepsis (7 cases (15%)), and severe pneumonia (4 cases (9%)). Neurological injury occurred in 18 neonates (38%) with major neurological events including intracranial hemorrhage (13 cases), subclinical seizures (7 cases), markedly suppressed electroencephalographic activity (2 cases), and cerebral infarction (1 case). The change in arterial partial pressure of carbon dioxide (PCO2) before and after ECMO initiation was greater in the neurological injury group than in the non-neurological injury group in 29 cases (P=0.023). No statistically difference was observed in baseline characteristics, ECMO operational parameters or anti-coagulation therapy (all P>0.05). The overall ECMO weaning success rate was 85% (40/47), with a survival-to-discharge rate of 72% (34/47). In the neurological injury group, 12 of 18 neonates were successfully weaned from ECMO and 7 survived to discharge, whereas in the non-neurological injury group, 28 of 29 neonates were successfully weaned and 27 survived to discharge. Both ECMO weaning success rate and survival to discharge rates were lower in the neurological injury group than in the non-neurological injury group (both P<0.05). Among 34 survivors followed up to 2 years of age, epilepsy occurred in 2 cases and cerebral palsy in 1 case, and 23 cases completed at least one neurodevelopmental assessment within 2 years of age, among whom 3 of 18 infants evaluated at 3 months of age showed abnormal neurodevelopmental findings. Conclusions: Neurological complications are prevalent during neonatal ECMO support, predominantly manifesting as intracranial hemorrhage and subclinical seizures, and are major contributors to mortality and adverse neurodevelopmental outcomes. Large fluctuations in PCO2 around ECMO initiation may be a critical factor for neurological injury. 目的: 探讨新生儿体外膜氧合(ECMO)治疗期间神经系统并发症的发生情况、危险因素及预后。 方法: 回顾性队列研究。纳入2020年3月至2025年8月广州医科大学附属妇女儿童医疗中心新生儿科接受ECMO治疗的47例患儿。收集患儿基线资料、ECMO运行参数、头颅影像学、脑电图及神经发育评估等结果。根据是否发生神经系统损伤分为神经系统损伤组和无神经系统损伤组。采用独立样本t检验、Mann-Whitney U检验、χ2检验或Fisher确切概率检验进行组间比较。 结果: 47例患儿中男35例(74%),出生胎龄39.4(38.0,40.0)周,出生体重3 200(2 855,3 440)g。原发疾病为新生儿持续性肺动脉高压17例(36%),胎粪吸入综合征14例(30%),新生儿败血症7例(15%),重症肺炎4例(9%)。ECMO治疗期间18例(38%)出现神经系统损伤,无神经系统损伤组29例。神经系统损伤包括颅内出血13例、惊厥7例均为亚临床发作、脑电图显著抑制2例和脑梗死1例。神经系统损伤组ECMO启动前后动脉血二氧化碳分压(PCO2)差值高于无神经系统损伤组(P=0.023),两组ECMO启动前基线情况、ECMO运行参数、抗凝治疗等方面差异均无统计学意义(均P>0.05)。ECMO撤机成功40例(85%),出院存活34例(72%)。神经系统损伤组18例中成功撤机12例、存活出院7例,无神经系统损伤组29例中成功撤机28例、存活出院27例,神经系统损伤组的成功撤机率和出院存活率均低于无损伤组(均P<0.05)。34例存活患儿随访至2岁,发生癫痫2例、脑性瘫痪1例,23例患儿在24月龄内完成至少1次神经发育评估,其中3月龄神经发育评估18例患儿中异常3例。 结论: 新生儿ECMO治疗期间神经系并发症发生率较高,以颅内出血和亚临床惊厥为主,是造成死亡和不良神经发育预后的重要原因。ECMO启动前PCO2的急剧波动可能是神经损伤的危险因素。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li F, Rong X, Chen XW, et al. [Clinical analysis of neurologic complications in neonates during extracorporeal membrane oxygenation support]. Zhonghua Er Ke Za Zhi. 2026. PMID: 41539955. doi:10.3760/cma.j.cn112140-20251030-00964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。